Global Point-of-care Testing (POCT) for Chronic Disease Market Growth 2026-2032
The global Point-of-care Testing (POCT) for Chronic Disease market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Point-of-care Testing (POCT) for Chronic Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Point-of-care Testing (POCT) for Chronic Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Point-of-care Testing (POCT) for Chronic Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Point-of-care Testing (POCT) for Chronic Disease players cover Abbott, BioMerieux, Siemens Healthineers, Roche, Danaher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Point-of-care Testing (POCT) for Chronic Disease Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Chronic Disease sales in 2025, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Chronic Disease sales for 2026 through 2032. With Point-of-care Testing (POCT) for Chronic Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Chronic Disease industry.
This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Chronic Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Chronic Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Point-of-care Testing (POCT) for Chronic Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Chronic Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Chronic Disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Chronic Disease market by product type, application, key manufacturers and key regions and countries.
United States market for Point-of-care Testing (POCT) for Chronic Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Point-of-care Testing (POCT) for Chronic Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Point-of-care Testing (POCT) for Chronic Disease is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Point-of-care Testing (POCT) for Chronic Disease players cover Abbott, BioMerieux, Siemens Healthineers, Roche, Danaher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Point-of-care Testing (POCT) for Chronic Disease Industry Forecast” looks at past sales and reviews total world Point-of-care Testing (POCT) for Chronic Disease sales in 2025, providing a comprehensive analysis by region and market sector of projected Point-of-care Testing (POCT) for Chronic Disease sales for 2026 through 2032. With Point-of-care Testing (POCT) for Chronic Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-of-care Testing (POCT) for Chronic Disease industry.
This Insight Report provides a comprehensive analysis of the global Point-of-care Testing (POCT) for Chronic Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-of-care Testing (POCT) for Chronic Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Point-of-care Testing (POCT) for Chronic Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-of-care Testing (POCT) for Chronic Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-of-care Testing (POCT) for Chronic Disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Point-of-care Testing (POCT) for Chronic Disease market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Based on Immunochromatography
- Based on Chemiluminescence Technology
- Based on Biosensor
- Others
Segmentation by Application:
- Hospital
- lndependent Testing Organization
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott
- BioMerieux
- Siemens Healthineers
- Roche
- Danaher
- Sinocare Inc
- Assure Tech (Hangzhou) Co.,Ltd.
- Bio-Rad Laboratories
- Guangzhou Wondfo Biotech Co.,Ltd.
- Wuhan Easy Diagnosis Biomedicine Co.,ltd.
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Point-of-care Testing (POCT) for Chronic Disease market?
- What factors are driving Point-of-care Testing (POCT) for Chronic Disease market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Point-of-care Testing (POCT) for Chronic Disease market opportunities vary by end market size?
- How does Point-of-care Testing (POCT) for Chronic Disease break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Point-of-care Testing (POCT) for Chronic Disease by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Point-of-care Testing (POCT) for Chronic Disease by Country/Region, 2021, 2025 & 2032
2.2 Point-of-care Testing (POCT) for Chronic Disease Segment by Type
2.2.1 Based on Immunochromatography
2.2.2 Based on Chemiluminescence Technology
2.2.3 Based on Biosensor
2.2.4 Others
2.2.5 Point-of-care Testing (POCT) for Chronic Disease Sales by Type
2.2.5.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
2.2.5.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Type (2021-2026)
2.3 Point-of-care Testing (POCT) for Chronic Disease Segment by Application
2.3.1 Hospital
2.3.2 lndependent Testing Organization
2.3.3 Point-of-care Testing (POCT) for Chronic Disease Sales by Application
2.3.3.1 Global Point-of-care Testing (POCT) for Chronic Disease Sale Market Share by Application (2021-2026)
2.3.3.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Point-of-care Testing (POCT) for Chronic Disease Breakdown Data by Company
3.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales by Company (2021-2026)
3.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Company (2021-2026)
3.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue by Company (2021-2026)
3.2.1 Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Company (2021-2026)
3.2.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Company (2021-2026)
3.3 Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Company
3.4 Key Manufacturers Point-of-care Testing (POCT) for Chronic Disease Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-care Testing (POCT) for Chronic Disease Product Location Distribution
3.4.2 Players Point-of-care Testing (POCT) for Chronic Disease Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR CHRONIC DISEASE BY GEOGRAPHIC REGION
4.1 World Historic Point-of-care Testing (POCT) for Chronic Disease Market Size by Geographic Region (2021-2026)
4.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Point-of-care Testing (POCT) for Chronic Disease Market Size by Country/Region (2021-2026)
4.2.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales by Country/Region (2021-2026)
4.2.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue by Country/Region (2021-2026)
4.3 Americas Point-of-care Testing (POCT) for Chronic Disease Sales Growth
4.4 APAC Point-of-care Testing (POCT) for Chronic Disease Sales Growth
4.5 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Growth
4.6 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Growth
5 AMERICAS
5.1 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Country
5.1.1 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026)
5.1.2 Americas Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026)
5.2 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
5.3 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Region
6.1.1 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2021-2026)
6.1.2 APAC Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2021-2026)
6.2 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
6.3 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Point-of-care Testing (POCT) for Chronic Disease by Country
7.1.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026)
7.1.2 Europe Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026)
7.2 Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
7.3 Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease by Country
8.1.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026)
8.1.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026)
8.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
8.3 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Chronic Disease
10.3 Manufacturing Process Analysis of Point-of-care Testing (POCT) for Chronic Disease
10.4 Industry Chain Structure of Point-of-care Testing (POCT) for Chronic Disease
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-care Testing (POCT) for Chronic Disease Distributors
11.3 Point-of-care Testing (POCT) for Chronic Disease Customer
12 WORLD FORECAST REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR CHRONIC DISEASE BY GEOGRAPHIC REGION
12.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size Forecast by Region
12.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Forecast by Region (2027-2032)
12.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Point-of-care Testing (POCT) for Chronic Disease Forecast by Type (2027-2032)
12.7 Global Point-of-care Testing (POCT) for Chronic Disease Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.1.3 Abbott Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 BioMerieux
13.2.1 BioMerieux Company Information
13.2.2 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.2.3 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioMerieux Main Business Overview
13.2.5 BioMerieux Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.4.3 Roche Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Danaher
13.5.1 Danaher Company Information
13.5.2 Danaher Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.5.3 Danaher Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Danaher Main Business Overview
13.5.5 Danaher Latest Developments
13.6 Sinocare Inc
13.6.1 Sinocare Inc Company Information
13.6.2 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.6.3 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sinocare Inc Main Business Overview
13.6.5 Sinocare Inc Latest Developments
13.7 Assure Tech (Hangzhou) Co.,Ltd.
13.7.1 Assure Tech (Hangzhou) Co.,Ltd. Company Information
13.7.2 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.7.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Assure Tech (Hangzhou) Co.,Ltd. Main Business Overview
13.7.5 Assure Tech (Hangzhou) Co.,Ltd. Latest Developments
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Information
13.8.2 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Rad Laboratories Main Business Overview
13.8.5 Bio-Rad Laboratories Latest Developments
13.9 Guangzhou Wondfo Biotech Co.,Ltd.
13.9.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
13.9.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.9.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangzhou Wondfo Biotech Co.,Ltd. Main Business Overview
13.9.5 Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
13.10 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
13.10.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
13.10.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.10.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Main Business Overview
13.10.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Point-of-care Testing (POCT) for Chronic Disease by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Point-of-care Testing (POCT) for Chronic Disease by Country/Region, 2021, 2025 & 2032
2.2 Point-of-care Testing (POCT) for Chronic Disease Segment by Type
2.2.1 Based on Immunochromatography
2.2.2 Based on Chemiluminescence Technology
2.2.3 Based on Biosensor
2.2.4 Others
2.2.5 Point-of-care Testing (POCT) for Chronic Disease Sales by Type
2.2.5.1 Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
2.2.5.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Type (2021-2026)
2.3 Point-of-care Testing (POCT) for Chronic Disease Segment by Application
2.3.1 Hospital
2.3.2 lndependent Testing Organization
2.3.3 Point-of-care Testing (POCT) for Chronic Disease Sales by Application
2.3.3.1 Global Point-of-care Testing (POCT) for Chronic Disease Sale Market Share by Application (2021-2026)
2.3.3.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Point-of-care Testing (POCT) for Chronic Disease Breakdown Data by Company
3.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales by Company (2021-2026)
3.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Company (2021-2026)
3.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue by Company (2021-2026)
3.2.1 Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Company (2021-2026)
3.2.2 Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Company (2021-2026)
3.3 Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Company
3.4 Key Manufacturers Point-of-care Testing (POCT) for Chronic Disease Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-of-care Testing (POCT) for Chronic Disease Product Location Distribution
3.4.2 Players Point-of-care Testing (POCT) for Chronic Disease Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR CHRONIC DISEASE BY GEOGRAPHIC REGION
4.1 World Historic Point-of-care Testing (POCT) for Chronic Disease Market Size by Geographic Region (2021-2026)
4.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Point-of-care Testing (POCT) for Chronic Disease Market Size by Country/Region (2021-2026)
4.2.1 Global Point-of-care Testing (POCT) for Chronic Disease Annual Sales by Country/Region (2021-2026)
4.2.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue by Country/Region (2021-2026)
4.3 Americas Point-of-care Testing (POCT) for Chronic Disease Sales Growth
4.4 APAC Point-of-care Testing (POCT) for Chronic Disease Sales Growth
4.5 Europe Point-of-care Testing (POCT) for Chronic Disease Sales Growth
4.6 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Growth
5 AMERICAS
5.1 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Country
5.1.1 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026)
5.1.2 Americas Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026)
5.2 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
5.3 Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Region
6.1.1 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2021-2026)
6.1.2 APAC Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2021-2026)
6.2 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
6.3 APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Point-of-care Testing (POCT) for Chronic Disease by Country
7.1.1 Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026)
7.1.2 Europe Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026)
7.2 Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
7.3 Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease by Country
8.1.1 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026)
8.1.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026)
8.2 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026)
8.3 Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Chronic Disease
10.3 Manufacturing Process Analysis of Point-of-care Testing (POCT) for Chronic Disease
10.4 Industry Chain Structure of Point-of-care Testing (POCT) for Chronic Disease
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-of-care Testing (POCT) for Chronic Disease Distributors
11.3 Point-of-care Testing (POCT) for Chronic Disease Customer
12 WORLD FORECAST REVIEW FOR POINT-OF-CARE TESTING (POCT) FOR CHRONIC DISEASE BY GEOGRAPHIC REGION
12.1 Global Point-of-care Testing (POCT) for Chronic Disease Market Size Forecast by Region
12.1.1 Global Point-of-care Testing (POCT) for Chronic Disease Forecast by Region (2027-2032)
12.1.2 Global Point-of-care Testing (POCT) for Chronic Disease Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Point-of-care Testing (POCT) for Chronic Disease Forecast by Type (2027-2032)
12.7 Global Point-of-care Testing (POCT) for Chronic Disease Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.1.3 Abbott Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 BioMerieux
13.2.1 BioMerieux Company Information
13.2.2 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.2.3 BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 BioMerieux Main Business Overview
13.2.5 BioMerieux Latest Developments
13.3 Siemens Healthineers
13.3.1 Siemens Healthineers Company Information
13.3.2 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.3.3 Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Siemens Healthineers Main Business Overview
13.3.5 Siemens Healthineers Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.4.3 Roche Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Danaher
13.5.1 Danaher Company Information
13.5.2 Danaher Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.5.3 Danaher Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Danaher Main Business Overview
13.5.5 Danaher Latest Developments
13.6 Sinocare Inc
13.6.1 Sinocare Inc Company Information
13.6.2 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.6.3 Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sinocare Inc Main Business Overview
13.6.5 Sinocare Inc Latest Developments
13.7 Assure Tech (Hangzhou) Co.,Ltd.
13.7.1 Assure Tech (Hangzhou) Co.,Ltd. Company Information
13.7.2 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.7.3 Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Assure Tech (Hangzhou) Co.,Ltd. Main Business Overview
13.7.5 Assure Tech (Hangzhou) Co.,Ltd. Latest Developments
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Information
13.8.2 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.8.3 Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bio-Rad Laboratories Main Business Overview
13.8.5 Bio-Rad Laboratories Latest Developments
13.9 Guangzhou Wondfo Biotech Co.,Ltd.
13.9.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
13.9.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.9.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Guangzhou Wondfo Biotech Co.,Ltd. Main Business Overview
13.9.5 Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
13.10 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
13.10.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
13.10.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
13.10.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Main Business Overview
13.10.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Point-of-care Testing (POCT) for Chronic Disease Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Point-of-care Testing (POCT) for Chronic Disease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Based on Immunochromatography
Table 4. Major Players of Based on Chemiluminescence Technology
Table 5. Major Players of Based on Biosensor
Table 6. Major Players of Others
Table 7. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 8. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Table 9. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Type (2021-2026) & ($ million)
Table 10. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Type (2021-2026)
Table 11. Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Point-of-care Testing (POCT) for Chronic Disease Sale by Application (2021-2026) & (K Units)
Table 13. Global Point-of-care Testing (POCT) for Chronic Disease Sale Market Share by Application (2021-2026)
Table 14. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Application (2021-2026) & ($ million)
Table 15. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Application (2021-2026)
Table 16. Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Company (2021-2026) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Company (2021-2026)
Table 19. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Company (2021-2026)
Table 21. Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Point-of-care Testing (POCT) for Chronic Disease Producing Area Distribution and Sales Area
Table 23. Players Point-of-care Testing (POCT) for Chronic Disease Products Offered
Table 24. Point-of-care Testing (POCT) for Chronic Disease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share Geographic Region (2021-2026)
Table 29. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country/Region (2021-2026)
Table 33. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026) & (K Units)
Table 36. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2021-2026)
Table 37. Americas Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 39. Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 40. APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2021-2026) & (K Units)
Table 41. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region (2021-2026)
Table 42. APAC Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 44. APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 45. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026) & (K Units)
Table 46. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 48. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Point-of-care Testing (POCT) for Chronic Disease
Table 54. Key Market Challenges & Risks of Point-of-care Testing (POCT) for Chronic Disease
Table 55. Key Industry Trends of Point-of-care Testing (POCT) for Chronic Disease
Table 56. Point-of-care Testing (POCT) for Chronic Disease Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Point-of-care Testing (POCT) for Chronic Disease Distributors List
Table 59. Point-of-care Testing (POCT) for Chronic Disease Customer List
Table 60. Global Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Point-of-care Testing (POCT) for Chronic Disease Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Point-of-care Testing (POCT) for Chronic Disease Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Abbott Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 75. Abbott Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 76. Abbott Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Abbott Main Business
Table 78. Abbott Latest Developments
Table 79. BioMerieux Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 80. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 81. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. BioMerieux Main Business
Table 83. BioMerieux Latest Developments
Table 84. Siemens Healthineers Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 85. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 86. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Siemens Healthineers Main Business
Table 88. Siemens Healthineers Latest Developments
Table 89. Roche Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 91. Roche Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Danaher Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 95. Danaher Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 96. Danaher Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Danaher Main Business
Table 98. Danaher Latest Developments
Table 99. Sinocare Inc Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 100. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 101. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Sinocare Inc Main Business
Table 103. Sinocare Inc Latest Developments
Table 104. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 105. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 106. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Assure Tech (Hangzhou) Co.,Ltd. Main Business
Table 108. Assure Tech (Hangzhou) Co.,Ltd. Latest Developments
Table 109. Bio-Rad Laboratories Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 110. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 111. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bio-Rad Laboratories Main Business
Table 113. Bio-Rad Laboratories Latest Developments
Table 114. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 115. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 116. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Guangzhou Wondfo Biotech Co.,Ltd. Main Business
Table 118. Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
Table 119. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 120. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 121. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Main Business
Table 123. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Latest Developments
Table 1. Point-of-care Testing (POCT) for Chronic Disease Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Point-of-care Testing (POCT) for Chronic Disease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Based on Immunochromatography
Table 4. Major Players of Based on Chemiluminescence Technology
Table 5. Major Players of Based on Biosensor
Table 6. Major Players of Others
Table 7. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 8. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Table 9. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Type (2021-2026) & ($ million)
Table 10. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Type (2021-2026)
Table 11. Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Point-of-care Testing (POCT) for Chronic Disease Sale by Application (2021-2026) & (K Units)
Table 13. Global Point-of-care Testing (POCT) for Chronic Disease Sale Market Share by Application (2021-2026)
Table 14. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Application (2021-2026) & ($ million)
Table 15. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Application (2021-2026)
Table 16. Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Company (2021-2026) & (K Units)
Table 18. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Company (2021-2026)
Table 19. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Company (2021-2026)
Table 21. Global Point-of-care Testing (POCT) for Chronic Disease Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Point-of-care Testing (POCT) for Chronic Disease Producing Area Distribution and Sales Area
Table 23. Players Point-of-care Testing (POCT) for Chronic Disease Products Offered
Table 24. Point-of-care Testing (POCT) for Chronic Disease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share Geographic Region (2021-2026)
Table 29. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Point-of-care Testing (POCT) for Chronic Disease Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country/Region (2021-2026)
Table 33. Global Point-of-care Testing (POCT) for Chronic Disease Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026) & (K Units)
Table 36. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2021-2026)
Table 37. Americas Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 39. Americas Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 40. APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Region (2021-2026) & (K Units)
Table 41. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region (2021-2026)
Table 42. APAC Point-of-care Testing (POCT) for Chronic Disease Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 44. APAC Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 45. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026) & (K Units)
Table 46. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 48. Europe Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Point-of-care Testing (POCT) for Chronic Disease
Table 54. Key Market Challenges & Risks of Point-of-care Testing (POCT) for Chronic Disease
Table 55. Key Industry Trends of Point-of-care Testing (POCT) for Chronic Disease
Table 56. Point-of-care Testing (POCT) for Chronic Disease Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Point-of-care Testing (POCT) for Chronic Disease Distributors List
Table 59. Point-of-care Testing (POCT) for Chronic Disease Customer List
Table 60. Global Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Point-of-care Testing (POCT) for Chronic Disease Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Point-of-care Testing (POCT) for Chronic Disease Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Point-of-care Testing (POCT) for Chronic Disease Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Abbott Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 75. Abbott Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 76. Abbott Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Abbott Main Business
Table 78. Abbott Latest Developments
Table 79. BioMerieux Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 80. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 81. BioMerieux Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. BioMerieux Main Business
Table 83. BioMerieux Latest Developments
Table 84. Siemens Healthineers Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 85. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 86. Siemens Healthineers Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Siemens Healthineers Main Business
Table 88. Siemens Healthineers Latest Developments
Table 89. Roche Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 90. Roche Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 91. Roche Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Roche Main Business
Table 93. Roche Latest Developments
Table 94. Danaher Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 95. Danaher Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 96. Danaher Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Danaher Main Business
Table 98. Danaher Latest Developments
Table 99. Sinocare Inc Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 100. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 101. Sinocare Inc Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Sinocare Inc Main Business
Table 103. Sinocare Inc Latest Developments
Table 104. Assure Tech (Hangzhou) Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 105. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 106. Assure Tech (Hangzhou) Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Assure Tech (Hangzhou) Co.,Ltd. Main Business
Table 108. Assure Tech (Hangzhou) Co.,Ltd. Latest Developments
Table 109. Bio-Rad Laboratories Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 110. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 111. Bio-Rad Laboratories Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bio-Rad Laboratories Main Business
Table 113. Bio-Rad Laboratories Latest Developments
Table 114. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 115. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 116. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Guangzhou Wondfo Biotech Co.,Ltd. Main Business
Table 118. Guangzhou Wondfo Biotech Co.,Ltd. Latest Developments
Table 119. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Basic Information, Point-of-care Testing (POCT) for Chronic Disease Manufacturing Base, Sales Area and Its Competitors
Table 120. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Product Portfolios and Specifications
Table 121. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Point-of-care Testing (POCT) for Chronic Disease Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Main Business
Table 123. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Point-of-care Testing (POCT) for Chronic Disease
Figure 2. Point-of-care Testing (POCT) for Chronic Disease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-of-care Testing (POCT) for Chronic Disease Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Point-of-care Testing (POCT) for Chronic Disease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country/Region (2025)
Figure 10. Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Based on Immunochromatography
Figure 12. Product Picture of Based on Chemiluminescence Technology
Figure 13. Product Picture of Based on Biosensor
Figure 14. Product Picture of Others
Figure 15. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type in 2026
Figure 16. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Type (2021-2026)
Figure 17. Point-of-care Testing (POCT) for Chronic Disease Consumed in Hospital
Figure 18. Global Point-of-care Testing (POCT) for Chronic Disease Market: Hospital (2021-2026) & (K Units)
Figure 19. Point-of-care Testing (POCT) for Chronic Disease Consumed in lndependent Testing Organization
Figure 20. Global Point-of-care Testing (POCT) for Chronic Disease Market: lndependent Testing Organization (2021-2026) & (K Units)
Figure 21. Global Point-of-care Testing (POCT) for Chronic Disease Sale Market Share by Application (2025)
Figure 22. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Application in 2026
Figure 23. Point-of-care Testing (POCT) for Chronic Disease Sales by Company in 2026 (K Units)
Figure 24. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Company in 2026
Figure 25. Point-of-care Testing (POCT) for Chronic Disease Revenue by Company in 2026 ($ millions)
Figure 26. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Company in 2026
Figure 27. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 30. Americas Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 31. APAC Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 32. APAC Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 33. Europe Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 34. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 37. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country in 2026
Figure 38. Americas Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2021-2026)
Figure 39. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 40. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 41. United States Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region in 2026
Figure 46. APAC Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Region (2021-2026)
Figure 47. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 48. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 49. China Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 53. India Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country in 2026
Figure 57. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2021-2026)
Figure 58. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 59. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 60. Germany Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 61. France Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 68. Egypt Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Chronic Disease in 2026
Figure 74. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Chronic Disease
Figure 75. Industry Chain Structure of Point-of-care Testing (POCT) for Chronic Disease
Figure 76. Channels of Distribution
Figure 77. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Forecast by Region (2027-2032)
Figure 78. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Point-of-care Testing (POCT) for Chronic Disease
Figure 2. Point-of-care Testing (POCT) for Chronic Disease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Point-of-care Testing (POCT) for Chronic Disease Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Point-of-care Testing (POCT) for Chronic Disease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country/Region (2025)
Figure 10. Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Based on Immunochromatography
Figure 12. Product Picture of Based on Chemiluminescence Technology
Figure 13. Product Picture of Based on Biosensor
Figure 14. Product Picture of Others
Figure 15. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type in 2026
Figure 16. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Type (2021-2026)
Figure 17. Point-of-care Testing (POCT) for Chronic Disease Consumed in Hospital
Figure 18. Global Point-of-care Testing (POCT) for Chronic Disease Market: Hospital (2021-2026) & (K Units)
Figure 19. Point-of-care Testing (POCT) for Chronic Disease Consumed in lndependent Testing Organization
Figure 20. Global Point-of-care Testing (POCT) for Chronic Disease Market: lndependent Testing Organization (2021-2026) & (K Units)
Figure 21. Global Point-of-care Testing (POCT) for Chronic Disease Sale Market Share by Application (2025)
Figure 22. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Application in 2026
Figure 23. Point-of-care Testing (POCT) for Chronic Disease Sales by Company in 2026 (K Units)
Figure 24. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Company in 2026
Figure 25. Point-of-care Testing (POCT) for Chronic Disease Revenue by Company in 2026 ($ millions)
Figure 26. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Company in 2026
Figure 27. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 30. Americas Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 31. APAC Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 32. APAC Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 33. Europe Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 34. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Revenue 2021-2026 ($ millions)
Figure 37. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country in 2026
Figure 38. Americas Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2021-2026)
Figure 39. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 40. Americas Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 41. United States Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Region in 2026
Figure 46. APAC Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Region (2021-2026)
Figure 47. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 48. APAC Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 49. China Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 53. India Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country in 2026
Figure 57. Europe Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share by Country (2021-2026)
Figure 58. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 59. Europe Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 60. Germany Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 61. France Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Point-of-care Testing (POCT) for Chronic Disease Sales Market Share by Application (2021-2026)
Figure 68. Egypt Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Point-of-care Testing (POCT) for Chronic Disease Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Point-of-care Testing (POCT) for Chronic Disease in 2026
Figure 74. Manufacturing Process Analysis of Point-of-care Testing (POCT) for Chronic Disease
Figure 75. Industry Chain Structure of Point-of-care Testing (POCT) for Chronic Disease
Figure 76. Channels of Distribution
Figure 77. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Forecast by Region (2027-2032)
Figure 78. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Point-of-care Testing (POCT) for Chronic Disease Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Point-of-care Testing (POCT) for Chronic Disease Revenue Market Share Forecast by Application (2027-2032)
More Publications
Global Multiple Sclerosis Drugs Market Growth 2025-2031
US$ 3,660.00
October 2025
96 pages
Global Sandostatin LAR Market Growth 2024-2030
US$ 3,660.00
March 2024
79 pages
Global Glycated Hemoglobin Testing Equipment Market Growth 2026-2032
US$ 3,660.00
July 2026
141 pages
Global T-cell Engaging bsAbs Drugs Market Growth 2024-2030
US$ 3,660.00
June 2024
76 pages
